Pre-market
Loading markets…

Advertisement

Stocks

Why Conavi Medical Corp. stock is rising today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:CNVI.V

Follow CNVI

Photos provided by Pexels

Conavi Medical Corp. has seen a notable uptick in its stock price, closing up 4.65% in the last trading session.

Conavi Medical Corp. (CNVI.V) experienced a significant rise in its stock price, closing at CA$0.23, reflecting a 4.65% increase in just one day. This upward movement comes after some positive developments for the company, including successful fundraising efforts and advancements in medical imaging technology.

Investor takeaway: Investors may see Conavi Medical's recent stock performance as a sign of growing confidence in its operational capabilities and market potential, particularly in the medical technology sector.

Advertisement

Conavi Medical Corp.

CNVI.V

Full stock page →

CNVI.V

Conavi Medical Corp.

Source:WealthAwesomeWealthAwesome
↓ $0.25 (-63.29%)
120 day period
$0.14$0.31$0.48Apr 6Jun 30Sep 30

Market cap

$20.01M

52W high

$0.70

52W low

$0.14

1W change

-9.38%

Analyst Price Targets

Based on analyst covering CNVI · as of Sep 30, 2026

📈

Wall Street analysts forecast CNVI stock price to rise 796.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$1.30

+796.6% Upside

Previously C$1.00 on Sep 17, 2026

Current Price

C$0.14

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CNVI's historical volatility

HistoricalForecast68%95%
C$0.05C$0.10C$0.15C$0.20C$0.25C$0.30TodayMay 19Jul 24Sep 30Nov 12Dec 26Feb 7

30-Day Vol

67.8%

Annualized

90-Day Vol

91.6%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.12

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.14C$0.11 – C$0.17
60 trading daysC$0.13C$0.09 – C$0.18
90 trading daysC$0.12C$0.08 – C$0.18

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Conavi Medical Corp. Gains 4.65% in One Day

The stock's rise reflects a market cap of approximately CA$22.25 million, indicating investor optimism amidst recent fundraising successes.

Bull case

The successful closure of a $12 million public offering and advancements in hybrid imaging technology could signal a stronger financial position and innovative edge for Conavi Medical, attracting more investor interest.

Bear case

Despite the positive movement, investors should stay cautious. The company has yet to establish a consistent profit margin and faces inherent risks in the competitive medical technology landscape.

Recent Developments Fueling Growth

Advertisement

Conavi Medical recently reported the successful closure of a $12 million public offering, which is expected to strengthen its financial foundation. This funding will support the development of its Novasight 3.0 technology, a significant advancement in hybrid imaging that combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT). Such innovations are crucial for enhancing diagnostic capabilities in the medical field.

Market Response to Financial Performance

The stock's performance reflects market optimism regarding Conavi Medical's operational highlights and its ability to navigate the competitive medical technology landscape. Investors are likely encouraged by the company's strategic moves to enhance visibility and access to U.S. investors, especially with its recent uplisting to the OTCQB Venture Market. This could attract a broader investor base and increase trading volume.

Looking Ahead: Potential Challenges

While the recent gains are promising, investors should remain vigilant. Conavi Medical has yet to achieve consistent profitability, and the medical technology sector is filled with competition and regulatory challenges. Understanding these factors will be crucial for investors considering the long-term viability of their investment in CNVI.V.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 9, 2026
Last Updated: July 9, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement